On this page
Evidence dossier
The report behind the claim
The authors reported attenuation of cardiac and wider injury measures in the experimental groups. Chemically induced rat injury is not a clinical heart-attack treatment trial.
Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in Rats.
- Design
- Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
- Participants or model
- Rats given an experimental isoprenaline challenge
- Endpoint
- Cardiac electrical, biochemical, imaging and organ-injury findings
- Finding on record
- The authors reported attenuation of cardiac and wider injury measures in the experimental groups.
- Limits of inference
- Chemically induced rat injury is not a clinical heart-attack treatment trial.
The experiment in view
The study used rats given an experimental isoprenaline challenge. Its principal measures were cardiac electrical, biochemical, imaging and organ-injury findings. The authors reported attenuation of cardiac and wider injury measures in the experimental groups.
Reading the result closely
The label myocardial infarction can obscure how injury was induced. A chemical challenge has different context from a person's blocked coronary artery. Emergency treatment, survival, recurrent events and standard-care comparison cannot be inferred from favorable laboratory or imaging findings alone.
The boundary of the finding
Chemically induced rat injury is not a clinical heart-attack treatment trial.
Related evidence, kept separate
BPC-157 in monocrotaline-related pulmonary hypertension examines pulmonary pressure-related, heart and lung findings. Here, the measured endpoint was cardiac electrical, biochemical, imaging and organ-injury findings. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with the What changes when a BPC-157 paper becomes a sales claim? appraisal.
On the record
The documents supporting this report.